Women's Health

Read Avalere experts’ analysis and research findings on how coverage, care, and outcomes related to women’s health and health services are shaped by policymakers, industry, plans, and advocates.

Pranathi Sana

Cervical Cancer Screening Rates Differ Across Demographics

The majority of women are not receiving cervical cancer screenings in compliance with recommendations, with disparities by insurance and age.

Shivani Patel

Stakeholders Address Disparities in Breast Cancer Screening

Avalere found disparate breast cancer screening rates by race/ethnicity and insurance type. Stakeholders are seeking to address barriers to patient access.

Pranathi Sana

6 Ways the Mifepristone Rulings May Impact Future FDA Approvals

Conflicting court rulings regarding FDA approval of mifepristone, part of the regimen for medication abortion, may set a new precedent for product approvals.

Brook Getachew

Avalere Data on Breast Cancer Screening Disparities Published in AJMC

Avalere analysis conducted in collaboration with the Community Oncology Alliance (COA) was published in the American Journal of Managed Care, showing disparities in breast cancer screening rates during the COVID-19 pandemic among racial and ethnic minority groups and based on insurance type.

Patient Preferences in Triple Negative Breast Cancer Treatments

To determine the attributes of triple-negative breast cancer treatment that play a direct role in patient treatment decision making at treatment initiation and following initial treatment selection, Avalere conducted focus groups to examine treatment experiences of patients with triple-negative breast cancer and elicit their treatment-related preferences.

Reducing Maternal Mortality Among Women of Color

Women of color are disproportionately affected by pregnancy-related death in the US, which has a higher maternal mortality rate than 10 other developed nations worldwide.

Podcast: Obstetric Quality Terminology by AAPI Subgroups and Equitable Patient Engagement

Tune into our first episode of Avalere’s Journal Club Review podcast series on Avalere Health Essential Voice. In this segment, Courtney Ramus, Consultant in the Center for Healthcare Transformation and Jasmine Nicole Namata, Associate in the Associate Immersion Program discuss the findings, themes, and relevant application of a contemporary healthcare publication.

New Avalere Analysis Compares Varying Breast Cancer Screening Recommendations

In October, the American Cancer Society (ACS) released its recommendations for breast cancer screening. The guidelines, which apply to women with average breast cancer risk, recommend annual screening from age 45 to 54, with biennial screening recommended for women over age 55. This represents a notable departure from its 2003 guideline, which advocated annual mammography for women at age 40 and older. The dramatic change in screening recommendation is in line with the growing evidence of benefits and harms of breast cancer screening. However, varying guidelines from organizations, such as the U.S. Preventive Services Task Force (USPSTF) and National Comprehensive Cancer Network (NCCN) reveal that experts have not come to a complete agreement on this issue.

USPSTF Revisits Controversial Mammography Screening Recommendations

On Nov. 14, the U.S. Preventive Services Task Force (USPSTF) released a draft research plan for Public Comment on "Screening for Breast Cancer," which intends to re-evaluate the effectiveness of routine mammography screening in women age 40 and older.

Sign up to receive more insights about Women's Health
Please enter your email address to be notified when new Women's Health insights are published.

Back To Top